Pharmafile Logo
Pharmafocus logo
Advanced Search

SMIP

Showing 1 posts of 1 posts found.

AstraZeneca signs genome deal

November 13, 2012
Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia

October 27, 2026

Hot-tub therapy tested as potential treatment for peripheral artery disease

October 26, 2026

Raimond takes helm at Nuclera

October 26, 2026

Most advanced breast cancer patients treated in community settings, Phesi study finds

October 26, 2026

Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison

October 23, 2026